Physician profile
Robert J Defatta
NPI 1578697520
$5,639.87
in general payments reported to CMS, 2019-2025
24 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $1,822 · 2021: $482 · 2022: $268 · 2023: $1,250 · 2024: $725 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960 · Travel and Lodging: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.30 |
| Travel and Lodging | $286.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,089.90 | 2020 | |
| Aerin Medical INC. | $956.28 | 2023-2024 | |
| Inspire Medical Systems, INC. | $799.61 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $600.19 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $493.57 | 2020-2022 | |
| Acclarent, INC | $378.89 | 2019-2022 | |
| Medtronic, INC. | $216.39 | 2022-2024 | Propel, Sinuva, Ligasure |
| Preceptis Medical, INC. | $160.39 | 2020-2021 | |
| Genzyme Corporation | $150.32 | 2022-2025 | |
| Ethicon US, LLC | $144.40 | 2019-2024 | Ethicon, Surgicel Nu-Knit, Dermabond |
| Stryker Corporation | $134.06 | 2019-2024 | 1788 |
| Optinose US, INC. | $90.33 | 2019-2020 | |
| Alk-Abello, INC | $83.29 | 2019-2025 | Standardized Mite D. Farinae, Timothy, Standardized, Alternaria Tenuis |
| Glaxosmithkline, LLC. | $71.48 | 2022-2025 | Nucala |
| Zimmer Biomet Holdings, INC. | $54.34 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $36.85 | 2020 | |
| Organogenesis INC. | $26.17 | 2023 | Puraply |
| Cochlear Americas | $24.63 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Ambu INC. | $23.98 | 2023 | |
| Allergan, INC. | $23.88 | 2022 | |
| Karl Storz Endoscopy-America | $23.11 | 2022 | |
| Galderma Laboratories, L.P. | $22.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.40 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $16.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Defatta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.